Cargando…
Comparison of the Performance of the PanBio COVID-19 Antigen Test in SARS-CoV-2 B.1.1.7 (Alpha) Variants versus non-B.1.1.7 Variants
This study evaluates the performance of the PanBio COVID-19 antigen (Ag) test as part of a hospital infection control policy. Hospital staff was encouraged to get tested for COVID-19 when presenting with SARS-CoV-2-related symptoms. In a period of approximately 5 months, a steady decline in the perf...
Autores principales: | van Ogtrop, M. L., van de Laar, T. J. W., Eggink, D., Vanhommerig, J. W., van der Reijden, W. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612141/ https://www.ncbi.nlm.nih.gov/pubmed/34817226 http://dx.doi.org/10.1128/Spectrum.00884-21 |
Ejemplares similares
-
Tracking of SARS-CoV-2 Alpha variant (B.1.1.7) in Palestine
por: Nasereddin, Abedelmajeed, et al.
Publicado: (2022) -
Impact of SARS-CoV-2 Alpha variant (B.1.1.7) on prisons, England
por: Vusirikala, Amoolya, et al.
Publicado: (2022) -
UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates
por: Rosenke, Kyle, et al.
Publicado: (2021) -
Increased aerosol transmission for B.1.1.7 (alpha variant) over lineage A variant of SARS-CoV-2
por: Port, Julia, et al.
Publicado: (2021) -
Increased aerosol transmission for B.1.1.7 (alpha variant) over lineage A variant of SARS-CoV-2
por: Port, Julia R., et al.
Publicado: (2021)